<strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
    <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
  1. 
    
  2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

    <span id="fvzf9"><input id="fvzf9"></input></span>

  3. 掃碼關(guān)注公眾號           掃碼咨詢(xún)技術(shù)支持           掃碼咨詢(xún)技術(shù)服務(wù)
      
    客服熱線(xiàn):400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
    91综合精品国产丝袜长腿_產(chǎn)品中心-北京博奧森生物技術(shù)有限公司
    AGEs (bs-1158P)  
    訂購熱線(xiàn):400-901-9800
    訂購郵箱:sales@bioss.com.cn
    訂購QQ:  400-901-9800
    技術(shù)支持:techsupport@bioss.com.cn
    10mg/1280.00元
    50mg/4800.00元
    大包裝/詢(xún)價(jià)

    產(chǎn)品編號 bs-1158P
    英文名稱(chēng) AGEs
    中文名稱(chēng) 晚期糖基化終末產(chǎn)物AGEs蛋白
    別    名 AGEs  
    Specific References  (13)     |     bs-1158P has been referenced in 13 publications.
    [IF=8.755] Shiyu Lin. et al. Tetrahedral framework nucleic acids-based delivery promotes intracellular transfer of healing peptides and accelerates diabetic would healing. CELL PROLIFERAT. 2022 Jul 09  
    [IF=8.025] Bingfeng Lin. et al. Structural characterization and anti-osteoporosis effect of an arabinomannan from Anemarrhena asphodeloides Bge. INT J BIOL MACROMOL. 2023 Mar;231:123324  Rat.  
    [IF=7.658] Wenbo Mao. et al. Phloretin ameliorates diabetes-induced endothelial injury through AMPK-dependent anti-EndMT pathway. PHARMACOL RES. Pharmacol Res. 2022 May;179:106205  Other ;  Other.  
    [IF=6.208] Shengqi Huo. et al. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury. INT J MOL SCI. 2023 Jan;24(2):1667  Rat.  
    [IF=5.5] Ren X et al. Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration.(2018)Cell Physiol Biochem. 2018;50(5):1673-1686.  CCK-8 assay ;  
    [IF=4.268] Wang N et al. Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE/MAPK signaling pathways. Phytomedicine. 2020 May 24;75:153247.  Other ;  zebrafish.  
    [IF=4.044] Jinjuan Lv. et al. Sulforaphane delays diabetes-induced retinal photoreceptor cell degeneration. Cell Tissue Res. 2020 Dec;382(3):477-486  WB ;  Mouse.  
    [IF=3.269] Xiaohua Sun. et al. Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes. Bioengineered. 2021;12(1):4191-4200  WB ;  Human.  
    [IF=3.009] Tan, Hao. et al. Notch/NICD/RBP-J signaling axis regulates M1 polarization of macrophages mediated by advanced glycation end products. GLYCOCONJUGATE J. 2022 Jun;:1-11  
    [IF=2.965] Meng L et al. Human?α?defensins?promote?the?expression?of the?inflammatory?cytokine?interleukin-8?underhigh-glucose?conditions:?Novel?insights?into the?poor?healing?of?diabetic?foot ulcers. J Biochem Mol Toxicol. 2019 Jun 3:e22351.  Other ;  
    [IF=2.885] Yi Xiaowei. et al. NLRP10 promotes AGEs-induced NLRP1 and NLRP3 inflammasome activation via ROS/MAPK/NF-κB signaling in human periodontal ligament cells. ODONTOLOGY. 2023 Apr;:1-12  
    [IF=2.629] Zhao Shao-Yang. et al. A Study of the Protective Effect of Bushen Huoxue Prescription on Cerebral Microvascular Endothelia Based on Proteomics and Bioinformatics. Evid-Based Compl Alt. 2022;2022:2545074  Other ;  Other.  
    [IF=2.548] Zhang P et al. AGEs induce epithelial to mesenchymal transformation of human peritoneal mesothelial cells via upregulation of STAT3.Glycoconj J. 2019 Apr;36(2):155-163.  Other ;  
    克 隆 號
    理論分子量 kDa
    檢測分子量
    性    狀 Lyophilized or Liquid
    物    種 N/A
    序    列 Purified native protein
    純    度 >95% as determined by SDS-PAGE
    內毒素 Not analyzed
    活性 Yes
    緩 沖 液 PBS (pH=7.4).
    保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
    注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    產(chǎn)品介紹 Advanced Glycation End products (AGEs) are the result of a chain of chemical reactions after an initial glycation reaction. The intermediate products are known, variously, as Amadori, Schiff base and Maillard products, named after the researchers who first described them. (The literature is inconsistent in applying these terms. For example, Maillard reaction products are sometimes considered intermediates and sometimes end products.) Side products generated in intermediate steps may be oxidizing agents (such as hydrogen peroxide), or not (such as beta amyloid proteins).[1] "Glycosylation" is sometimes used for "glycation" in the literature, usually as 'non-enzymatic glycosylation. The AGE modified BSA was produced by reacting BSA with glycolaldehyde under sterile conditions followed by extensive dialysis and purification steps.


    AGEs又稱(chēng)非酶糖基化終末產(chǎn)物(AGEs) 是蛋白質(zhì)、脂質(zhì)和核酸等大分子的游離氨基與還原性單糖的醛基反應所生成的穩定的共價(jià)化合物, 在體內的積累、增多是導致糖尿病等多種疾病及其并發(fā)癥的關(guān)鍵因素。AGEs的異常增多,可直接或間接地對機體產(chǎn)生致病作用。

    晚期糖基化終末產(chǎn)物-AGEs的相關(guān)學(xué)說(shuō)
    晚期糖基化終末產(chǎn)物(Advanced glycation endproducts,AGEs)是一類(lèi)經(jīng)由糖,包括通過(guò)Maillard反應形成的代謝中間產(chǎn)物化學(xué)修飾的蛋白。AGEs具有高度交聯(lián)性。 AGE與AGE受體(如RAGE)的相互作用誘導了受體承載細胞核因子-Kap B(NF—Kap B)的活化,同時(shí)這一作用還誘導了細胞因子、生長(cháng)因子及黏附分子表達的增加。
    在糖尿病方面,晚期糖基化終末產(chǎn)物(AGEs)可引起體內組織一系列病理生理改變,是導致糖尿病慢性并發(fā)癥的重要致病因素。在健康人群中AGEs也隨年齡增加在組織中持續積累,并參與衰老過(guò)程。由于糖尿病和衰老均可導致骨代謝紊亂,甚至出現骨質(zhì)疏松及脫鈣。
    AGEs具有廣泛的致病作用:AGEs形成后引起蛋白質(zhì)分子間廣泛交聯(lián),致使蛋白質(zhì)結構、機械強度、溶解性和配位結合等性質(zhì)均發(fā)生改變。體內多種蛋白質(zhì)糖基化可從多個(gè)方面影響機體,如引起血管通透性增大、血管基底膜增厚和細胞外基質(zhì)積聚等。AGEs與其細胞表面受體(RAGE)結合,通過(guò)趨化和活化單核巨噬細胞,激活轉錄因子NF-KB,促進(jìn)細胞因子和組織因子的釋放,滅活一氧化氮和產(chǎn)生氧自由基等途徑,參與糖尿病慢性并發(fā)癥的發(fā)生和發(fā)展 。由于A(yíng)GEs的不可逆性,即使高血糖被糾正后,AGEs水平也不能回復到正常,而繼續在組織中累積。從組織AGEs自然解釋出的反應中間物,如不能經(jīng)腎臟消除,可再次結合到其他結構上,發(fā)生AGEs的“第二次”或“第三次”生成,致病作用加重。
    產(chǎn)品圖片
    外觀(guān)及包裝
    版權所有 2004-2026 radiasunchina.com 北京博奧森生物技術(shù)有限公司
    通過(guò)國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書(shū)編號: 00124Q34771R2M/1100
    通過(guò)國際醫療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書(shū)編號: CQC24QY10047R0M/1100
    京ICP備05066980號-1         京公網(wǎng)安備110107000727號
    国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
    <strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
      <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
    1. 
      
    2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

      <span id="fvzf9"><input id="fvzf9"></input></span>